High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients

Maiorca, 1993, Morbidity and mortality of CAPD and hemodialysis, Kidney Int, 43, S4 Ma, 1992, Cardiovascular risk factors in chronic renal failure and hemodialysis populations, Am J Kid Dis, 19, 505, 10.1016/S0272-6386(12)80827-4 Parfrey, 1994, Long term cardiac morbidity and mortality during dialysis therapy, Adv Nephrol, 23, 311 Ueland, 1992, Plasma homocysteine and cardiovascular disease, 182 Stampfer, 1992, A prospective study of plasma homocyst(e)ine and the risk of myocardial infarction in US physicians, JAMA, 268, 877, 10.1001/jama.1992.03490070059042 Arnesen, 1993, The Tromso Study: Serum total homocysteine and myocardial infarction, a prospective study Selhub, 1995, Association between plasma homocysteine concentrations and extracranial carotid artery stenosis, N Engl J Med, 332, 286, 10.1056/NEJM199502023320502 Wilcken, 1979, Sulphur-containing amino acids in chronic renal failure with particular reference to cysteine-homocysteine mixed disulfide, Eur J Clin Invest, 9, 301, 10.1111/j.1365-2362.1979.tb00888.x Wilcken, 1980, Accumulation of sulphur-containing amino acids including cysteine-homocysteine mixed disulfide in patients on hemodialysis, Clin Sci, 58, 427, 10.1042/cs0580427 Kang, 1983, Plasma protein-bound homocyst(e)ine in patients requiring chronic hemodialysis, Clin Sci, 65, 335, 10.1042/cs0650335 Chauveau, 1993, Hyperhomocyst(e)inemia, a risk factor for atherosclerosis in chronic uremic patients, Kidney Int, 43, S72 Hultberg, 1993, Plasma homocysteine in renal failure, Clin Nephrol, 40, 230 Bostom, 1995, Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case control study, Atherosclerosis, 114, 93, 10.1016/0021-9150(94)05470-4 Bostom, 1995, Excess prevalence of hyperhomocysteinemia in dialysis-dependent end-stage renal disease, Irish J Med Sci, 164, 3 Brattstrom, 1988, Folic acid-An innocuous means of reducing plasma homocysteine, Scand J Clin Lab Invest, 48, 215, 10.3109/00365518809167487 Ubbink, 1993, Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia, Am J Clin Nutr, 57, 47, 10.1093/ajcn/57.1.47 Ubbink, 1994, Vitamin requirements for the treatment of hyperhomocysteinemia in humans, J Nutr, 124, 1927, 10.1093/jn/124.10.1927 Brattstrom, 1990, Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease, Atherosclerosis, 81, 51, 10.1016/0021-9150(90)90058-Q Selhub, 1991, The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosyl-methionine of the remethylation and transsulfuration of homocysteine, Am J Clin Nutr, 55, 131, 10.1093/ajcn/55.1.131 Ueland, 1993, Total homocysteine in plasma or serum: Methods and applications, Clin Chem, 39, 1764, 10.1093/clinchem/39.9.1764 Arnadottir, 1993, The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients, Clin Nephrol, 40, 236 Janssen MJ, 1993, Folic acid lowers elevated homocysteine levels in chronic dialysis patients, J Am Soc Nephrol, 4, 250 Guldener, 1994, Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients, Perit Dial Int, 14, S-26 Araki, 1987, Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection, J Chromatogr, 422, 43, 10.1016/0378-4347(87)80438-3 Shin-Buering, 1981, A new enzymatic method for pyridoxal 5′-phosphate determination, J Inherit Metab Dis, 4, 123, 10.1007/BF02263621 Horne, 1988, Lactobacillus casei assay of folic acid derivatives in 96-well microtiter plates, Clin Chem, 34, 2357, 10.1093/clinchem/34.11.2357 1991 Ueland, 1989, Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy, J Lab Clin Med, 114, 473 Bostom, 1995, Net uptake of plasma homocysteine by the rat kidney in vivo, Atherosclerosis, 116, 59, 10.1016/0021-9150(95)05522-X Livant, 1994, Plasma folate conjugase activites and folate concentrations in patients receiving hemodialysis, J Nutr Biochem, 5, 504, 10.1016/0955-2863(94)90031-0 Krumdieck, 1986, Folates in tissues and cells. Support for a “two tier” hypothesis of one carbon metabolism, 447 Harker, 1976, Homocystine-induced arteriosclerosis. The role of endothelial injury and platelet response in its genesis, J Clin Invest, 58, 731, 10.1172/JCI108520 Wall, 1980, Homocystine-induced endothelial injury in vitro: A model for the study of vascular injury, Thromb Res, 18, 113, 10.1016/0049-3848(80)90175-9 Heinecke, 1987, The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells, J Biol Chem, 262, 10098, 10.1016/S0021-9258(18)61082-8 Di Minno, 1993, Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence efor platelet involvement and probucol-sensitive mechanism, J Clin Invest, 92, 1400, 10.1172/JCI116715 Lentz, 1991, Inhibition of thrombomodulin surface expression and protein C activitation by the thrombogenic agent homocysteine, J Clin Invest, 88, 1906, 10.1172/JCI115514 Harpel, 1992, Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein (a) to fibrin: A potential link betwen thrombosis, atherogenesis, and sulfhydryl compound metabolism, Proc Natl Acad Sci USA, 89, 10193, 10.1073/pnas.89.21.10193 Tsai, 1994, Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis, Proc Natl Acad Sci USA, 91, 6369, 10.1073/pnas.91.14.6369 Rolland, 1995, Hyperhomocysteinemia-induced vascular damage in the mini-pig, Circulation, 91, 1161, 10.1161/01.CIR.91.4.1161 Mudd, 1985, The natural history of homocystinuria due to cystathionine beta synthase deficiency, Am J Hum Genet, 37, 1 Massy, 1994, Hyperhomocysteinemia: A significant risk factor for cardiovascular disease in renal transplant recipients, Nephrol Dial Transplant, 9, 1103, 10.1093/ndt/9.8.1103 O'Leary, 1992, Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study, Stroke, 23, 1752, 10.1161/01.STR.23.12.1752 Butterworth, 1989, Folic acid safety and toxicity: A brief review, Am J Clin Nutr, 50, 353, 10.1093/ajcn/50.2.353 Takenaka, 1993, Effect of folic acid treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency, Clin Neurol (Jpn), 33, 1140